![]() |
市場調査レポート
商品コード
1738820
ポータブル酸素濃縮器の世界市場規模:製品カテゴリー別、流量容量別、エンドユーザー別、地域別、範囲および予測Global Portable Oxygen Concentrators Market Size By Product Category, By Flow Rate Capacity (Low Flow POCs, Medium Flow POCs, High Flow POCs ), By End-User, By Geographic Scope and Forecast |
||||||
|
ポータブル酸素濃縮器の世界市場規模:製品カテゴリー別、流量容量別、エンドユーザー別、地域別、範囲および予測 |
出版日: 2025年05月06日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
|
ポータブル酸素濃縮器市場規模は、2024年に15億6,000万米ドルと評価され、2026年から2032年にかけてCAGR 8.76%で成長し、2032年には30億4,000万米ドルに達すると予測されます。
ポータブル酸素濃縮器(POC)は、周囲の空気を濾過して濃縮し、呼吸障害を患っている人々に補助酸素を供給する軽量装置です。
患者が最大限の健康を維持するために十分な酸素を得られるようにするため、在宅介護環境、病院、旅行中に一般的に使用されています。
技術開発により、より小型で効率的な装置が開発され、使用者の快適性と移動性が向上していることから、POCの将来は楽観的であると思われます。慢性呼吸器疾患の頻度が上昇し、在宅ヘルスケアソリューションの需要が開拓されるにつれて、ポータブル酸素濃縮器市場は、より良い患者管理のためのスマートな機能と接続性の向上により、急速に拡大すると予測されます。
主な市場促進要因
高齢化と平均寿命の伸び:世界保健機関(WHO)によると、60歳以上の世界人口は2015年から2050年の間に12%から22%へと3倍に増加します。2030年には、6人に1人が60歳以上となり、世界で14億人が60歳以上となります。このグループは、酸素療法を必要とする持続性呼吸器疾患にかかりやすいです。
COPDの有病率の上昇:Global Initiative for Chronic Obstructive Lung Disease(GOLD)によると、COPDは2023年現在、全世界でおよそ3億8,400万人が罹患しており、2050年には5億9,200万人に増加すると予想されています。世界保健機関(WHO)によると、COPDは世界第3位の死因であり、2019年には323万人が死亡しています。
拡大する在宅ヘルスケア市場:在宅ヘルスケアサービスへの移行は、特に流行後に加速しています。メディケア・メディケイド・サービスセンター(CMS)によると、米国の在宅医療費は2021年に1,237億米ドルに達し、年間成長率は6.2%に達します。患者は在宅酸素療法を選択するため、この開発はPOC需要に直接的な影響を与えます。
大気汚染と環境要因の増加:世界銀行は、大気汚染が毎年700万人の早期死亡の原因となっており、10人中9人が汚染度の高い空気を吸っていると推定しています。世界保健機関(WHO)によると、世界人口の99%がWHOの汚染ガイドラインを超える空気を吸っており、その結果、酸素療法が必要となる呼吸困難が増加しています。
主な課題
高価格:ポータブル酸素濃縮器は高価であるため、酸素濃縮器を使用する多くの患者にとって利用しにくいものとなっています。特にヘルスケアへの資金援助や保険適用がほとんどない地域では、初期投資が大きいことが潜在的な利用者を遠ざける可能性があります。
技術的限界:POCは進歩してきたとはいえ、従来の酸素供給装置と比較すると、酸素流量や電池寿命の点で限界があります。より高い流量を必要とする患者はPOCでは不十分と感じる可能性があり、POCの適用はより重篤な状態に限定されます。
規制上の障害:ポータブル酸素濃縮器のメーカーは、規制状況を乗り切るのが難しいと感じるかもしれないです。各国間で異なる基準への準拠は、製品開発と市場参入を遅らせ、可用性と革新性を低下させる可能性があります。
ユーザーのコンプライアンスと教育:患者がPOCの使用方法とメンテナンス方法を確実に理解することは、有効性を高めるために極めて重要です。十分な教育や支援がない場合、過剰使用や有効性の低下、使用者の深刻な健康問題につながる可能性があります。
主な動向
技術の進歩:バッテリー技術の向上と小型化により、より軽量で効率的な携帯用酸素濃縮器がもたらされています。こうした開発により携帯性と有用性が向上し、患者の日常生活や旅行における柔軟性が高まっています。
在宅ヘルスケアへの注目の高まり:在宅ヘルスケアソリューションが重視されるようになり、在宅治療のためにポータブル酸素濃縮器を利用する患者が増加しています。この動向は、慢性呼吸器疾患の増加と、より快適な在宅ケアへの需要に後押しされています。
スマート機能の統合:新しいポータブル酸素濃縮器の多くは、スマートフォンとの接続や遠隔モニタリングなどのスマート技術を採用しています。これらの機能により、ヘルスケアプロバイダーは患者の使用状況をモニターし、リアルタイムで修正を加えることができるため、患者の管理と治療成績が向上します。
意識の高まりと教育:呼吸器疾患と酸素療法の重要性に対する人々の認識が高まるにつれ、ポータブル酸素濃縮器に対する需要も高まると思われます。ヘルスケア従事者や医療機関は、患者によりよい選択肢を啓発するための教育プログラムを実施しており、その結果コンプライアンスと使用率が向上しています。
Portable Oxygen Concentrators Market size was valued at USD 1.56 Billion in 2024 and is projected to reach USD 3.04 Billion by 2032, growing at a CAGR of 8.76% from 2026 to 2032.
Portable oxygen concentrators (POCs) are lightweight devices that filter and concentrate ambient air to deliver supplemental oxygen to those suffering from respiratory disorders.
They are commonly used in homecare settings, hospitals, and during travel to ensure that patients receive adequate oxygen for maximum health.
The future of POCs seems optimistic, as technological developments lead to smaller, more efficient devices that improve user comfort and mobility. As the frequency of chronic respiratory disorders rises and demand for home healthcare solutions develops, the portable oxygen concentrator market is predicted to expand rapidly, with smart features and increased connection for better patient management.
The key market dynamics that are shaping the global portable oxygen concentrators market include:
Key Market Drivers:
Aging Population and Rising Life Expectancy: According to the World Health Organization (WHO), the global population aged 60 and more will treble from 12% to 22% between 2015 and 2050. By 2030, one in every six persons will be 60 or older, totaling 1.4 billion people worldwide. This group is more prone to persistent respiratory diseases that necessitate oxygen therapy.
Rising Prevalence of COPD: According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), COPD affects roughly 384 million people worldwide as of 2023, with the number expected to rise to 592 million by 2050. According to the World Health Organization, COPD is the world's third biggest cause of death, accounting for 3.23 million deaths in 2019.
Growing Home Healthcare Market: The move to home healthcare services has accelerated, especially after the epidemic. According to the Centers for Medicare and Medicaid Services (CMS), home health spending in the United States will reach USD 123.7 Billion in 2021, representing a 6.2% annual growth rate. This development has a direct impact on POC demand, since patients choose home-based oxygen therapy.
Rising Air Pollution and Environmental Factors: The World Bank estimates that air pollution causes 7 million premature deaths each year, with 9 out of 10 People breathe air with high amounts of pollution. According to the World Health Organization, 99% of the world's population breaths air that exceeds WHO pollution guidelines, resulting in increasing respiratory difficulties that necessitate oxygen therapy.
Key Challenges:
High Prices: Portable oxygen concentrators can be costly, making them less accessible to many patients who use them. The large initial investment may dissuade potential users, particularly in areas with little healthcare financing or insurance coverage.
Technological Limits: While POCs have improved, they still have limits in terms of oxygen flow rates and battery life when compared to traditional oxygen delivery devices. Patients who require higher flow rates may find POCs insufficient, restricting their application to more severe conditions.
Regulatory Obstacles: Manufacturers of portable oxygen concentrators may find it difficult to navigate the regulatory landscape. Compliance with different standards between countries can delay down product development and market entry, reducing availability and innovation.
User Compliance and Education: Ensuring that patients understand how to use and maintain their POCs is critical for effectiveness. A lack of sufficient teaching and assistance might result in overuse, diminished effectiveness, and serious health problems for users.
Key Trends:
Technological Advancements: Improvements in battery technology and miniaturization are resulting in lighter, more efficient portable oxygen concentrators. These developments improve portability and usefulness, giving patients greater flexibility in their everyday activities and travel.
Increasing Focus on Home Healthcare: With a rising emphasis on home-based healthcare solutions, more patients are turning to portable oxygen concentrators for treatment at home. This trend is being driven by an increase in chronic respiratory disorders and a demand for more comfortable at-home care.
Integration of Smart Features: Many new portable oxygen concentrators use smart technologies, such as smartphone connectivity and remote monitoring. These capabilities enable healthcare providers to monitor patient usage and make real-time modifications, hence enhancing patient management and outcomes.
Growing Awareness and Education: As people become more aware of respiratory illnesses and the significance of oxygen therapy, there will be a growing demand for portable oxygen concentrators. Healthcare practitioners and organizations are implementing educational programs to better enlighten patients about their options, resulting in increased compliance and usage.
Here is a more detailed regional analysis of the global portable oxygen concentrators market:
North America:
North America dominates the portable oxygen concentrators market, owing to the high prevalence of chronic respiratory disorders and advanced healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC), around 16 million Americans have been diagnosed with chronic obstructive pulmonary disease (COPD), driving up demand for portable oxygen solutions. In October 2023, the American Respiratory Care Foundation highlighted the growing demand for home-based oxygen therapy, emphasizing the use of POCs in optimal disease management.
For instance, in September 2023, Philips announced the development of their portable oxygen concentrator line exclusively aimed at North American consumers, showing a deliberate response to rising market demand. Furthermore, the United States government's emphasis on enhancing healthcare accessibility and supporting home healthcare solutions is likely to fuel market expansion, establishing North America as a leader in the portable oxygen concentrators sector.
Asia Pacific:
The Asia Pacific area is now the fastest-growing market for portable oxygen concentrators, owing to rising air pollution levels and a higher frequency of respiratory disorders. According to the World Health Organization, around 4.2 million people in the region die each year as a result of outdoor air pollution, emphasizing the importance of appropriate respiratory care. According to a research from October 2023, the demand for oxygen therapy equipment in nations such as India and China is increasing as people become more aware of chronic illnesses like COPD and asthma.
For instance, in September 2023, the Indian government launched a new health program to improve home healthcare services, which involves providing portable oxygen concentrators to underprivileged areas. This program is intended to greatly increase the adoption of POCs, bolstering Asia Pacific's position as a fast rising market for portable oxygen concentrators.
The Global Portable Oxygen Concentrators Market is segmented on the basis of Product Category, Flow Rate Capacity, End-User, and Geography.
Based on Product Category, the Global Portable Oxygen Concentrators Market is segmented into Continuous Flow POCs, and Pulse Dosage POCs. The constant flow POCs segment is prominent, favored for its capacity to provide a consistent flow of oxygen, making it ideal for patients with more severe respiratory needs. In contrast, the pulse dosage POCs market is the fastest-growing, owing to its lightweight design and energy economy, which appeal to active customers looking for portability and simplicity.
Based on Flow Rate Capacity, the Global Portable Oxygen Concentrators Market is segmented into Low Flow POCs, Medium Flow POCs (2-5 LPM), High Flow POCs (Above 5 LPM). The medium flow POCs (2-5 LPM) segment is prominent because it effectively serves the needs of a diverse spectrum of patients who require supplementary oxygen. The high flow POCs (over 5 LPM) sector is the fastest-growing, owing to rising need for increased oxygen delivery in more critical care scenarios, such as for patients with severe respiratory illnesses.
Based on End-User, the Global Portable Oxygen Concentrators Market is segmented into Homecare Settings, Hospitals and Clinics, Travel and Recreation, and Long-term Care Facilities. The homecare settings segment is dominating, owing to the growing number of patients who manage chronic respiratory illnesses at home. The travel and recreation market is the fastest-growing, driven by expanding consumer demand for mobility and convenience, allowing people to continue living active lifestyles while requiring supplemental oxygen.
Based on the Geography, the Global Portable Oxygen Concentrators Market are classified into North America, Europe, Asia Pacific, and Rest of the World. North America is the largest region, owing to its high frequency of respiratory disorders and modern healthcare infrastructure. Meanwhile, the Asia Pacific area is the fastest-growing market, driven by improved healthcare access, rising air pollution levels, and an aging population that need oxygen therapy.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.